UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 34

Sortiert nach

Pharmacokinetics and pharmacodynamics of curcumin

Advances in experimental medicine and biology, 2007, Vol.595, p.453

2007

Link zum Volltext

Verfügbarkeit prüfen

Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine

Cancer chemotherapy and pharmacology, 2007-07, Vol.60 (2), p.171-177

2007

Link zum Volltext

Verfügbarkeit prüfen

Do anthocyanins and anthocyanidins, cancer chemopreventive pigments in the diet, merit development as potential drugs?

Cancer chemotherapy and pharmacology, 2009-06, Vol.64 (1), p.201-211

2009

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and metabolism of the putative cancer chemopreventive agent cyanidin-3-glucoside in mice

Cancer chemotherapy and pharmacology, 2009-11, Vol.64 (6), p.1261-1268

2009

Link zum Volltext

Verfügbarkeit prüfen

Translating curcumin to the clinic for lung cancer prevention: evaluation of the preclinical evidence for its utility in primary, secondary, and tertiary prevention strategies

The Journal of pharmacology and experimental therapeutics, 2014-09, Vol.350 (3), p.483

2014

Link zum Volltext

Verfügbarkeit prüfen

Differential modulation of cyclooxygenase-mediated prostaglandin production by the putative cancer chemopreventive flavonoids tricin, apigenin and quercetin

Cancer chemotherapy and pharmacology, 2006-12, Vol.58 (6), p.816-825

2006

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and biological evaluation of novel flavonols as potential anti-prostate cancer agents

European journal of medicinal chemistry, 2012-08, Vol.54, p.952-958

2012

Link zum Volltext

Verfügbarkeit prüfen

Tissue distribution in mice and metabolism in murine and human liver of apigenin and tricin, flavones with putative cancer chemopreventive properties

Cancer chemotherapy and pharmacology, 2007-07, Vol.60 (2), p.257-266

2007

Link zum Volltext

Verfügbarkeit prüfen

Physiological modeling of formulated and crystalline 3,3'-diindolylmethane pharmacokinetics following oral administration in mice

Drug metabolism and disposition, 2004-06, Vol.32 (6), p.632

2004

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics in mice and metabolism in murine and human liver fractions of the putative cancer chemopreventive agents 3′,4′,5′,5,7-pentamethoxyflavone and tricin (4′,5,7-trihydroxy-3′,5′-dimethoxyflavone)

Cancer chemotherapy and pharmacology, 2011-02, Vol.67 (2), p.255-263

2011

Link zum Volltext

Verfügbarkeit prüfen

Preliminary safety evaluation of the putative cancer chemopreventive agent tricin, a naturally occurring flavone

Cancer chemotherapy and pharmacology, 2006-01, Vol.57 (1), p.1-6

2006

Link zum Volltext

Verfügbarkeit prüfen

Determination of anthocyanins in the urine of patients with colorectal liver metastases after administration of bilberry extract

Biomedical chromatography, 2011-06, Vol.25 (6), p.660-663

2011

Link zum Volltext

Verfügbarkeit prüfen

Consumption of silibinin, a flavonolignan from milk thistle, and mammary cancer development in the C3(1) SV40 T,t antigen transgenic multiple mammary adenocarcinoma (TAg) mouse

Cancer chemotherapy and pharmacology, 2008-07, Vol.62 (2), p.369-372

2008

Link zum Volltext

Verfügbarkeit prüfen

Tissue distribution and metabolism of the putative cancer chemopreventive agent 3′,4′,5′-trimethoxyflavonol (TMFol) in mice

Biomedical chromatography, 2012-12, Vol.26 (12), p.1559-1566

2012

Link zum Volltext

Verfügbarkeit prüfen

Determination of 3′,4′,5′,5,7-pentamethoxyflavone in the plasma and intestinal mucosa of mice by HPLC with UV detection

Biomedical chromatography, 2009-04, Vol.23 (4), p.335-339

2009

Link zum Volltext

Verfügbarkeit prüfen

Marimastat: the clinical development of a matrix metalloproteinase inhibitor

Expert opinion on investigational drugs, 2000-12, Vol.9 (12), p.2913-2922

2000

Link zum Volltext

Verfügbarkeit prüfen

Determination of the putative cancer chemopreventive flavone tricin in plasma and tissues of mice by HPLC with UV-visible detection

Biomedical chromatography, 2005-09, Vol.19 (7), p.518-522

2005

Link zum Volltext

Verfügbarkeit prüfen

A simple HPLC method for the determination of apigenin in mouse tissues

Biomedical chromatography, 2006-10, Vol.20 (10), p.1038-1042

2006

Link zum Volltext

Verfügbarkeit prüfen

Bioequivalence of two tablet formulations of capecitabine and exploration of age, gender, body surface area, and creatinine clearance as factors influencing systemic exposure in cancer patients

Cancer chemotherapy and pharmacology, 1999, Vol.44 (6), p.453-460

1999

Link zum Volltext

Verfügbarkeit prüfen

Somatostatin, Its Receptors and Analogs, in Lung Cancer

Chemotherapy (Basel), 2001, Vol.47 (2), p.78-108

2001

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of marimastat (BB-2516) in malignant melanoma: A clinical and tumor biopsy study of the National Cancer Institute of Canada Clinical Trials Group

Investigational new drugs, 2002-11, Vol.20 (4), p.431-437

2002

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of Caelyx, liposomal doxorubicin : lack of activity in patients with advanced gastric cancer

Cancer chemotherapy and pharmacology, 2001-10, Vol.48 (4), p.266-268

2001

Link zum Volltext

Verfügbarkeit prüfen

Determination of the ﬂavone tricin in human plasma by high-performance liquid chromatography

Biomedical chromatography, 2003-10, Vol.17 (7), p.435-439

2003

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the DNA Damaging Potential of Cannabis Cigarette Smoke by the Determination of Acetaldehyde Derived N 2 -Ethyl-2′-deoxyguanosine Adducts

Chemical research in toxicology, 2009-06, Vol.22 (6), p.1181-1188

2009

Link zum Volltext

Verfügbarkeit prüfen

Marimastat (BB2516) : Current status of development

Cancer chemotherapy and pharmacology, 1999, Vol.43 (7), p.S56-S60

STEWARD, W. P

1999

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 34

Suche als RSS-Feed

Aktive Filter

ThemaPharmacology & Pharmacy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(34)

Sprache

Englisch
(34)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacokinetics and pharmacodynamics of curcumin

Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine

Do anthocyanins and anthocyanidins, cancer chemopreventive pigments in the diet, merit development as potential drugs?

Pharmacokinetics and metabolism of the putative cancer chemopreventive agent cyanidin-3-glucoside in mice

Translating curcumin to the clinic for lung cancer prevention: evaluation of the preclinical evidence for its utility in primary, secondary, and tertiary prevention strategies

Differential modulation of cyclooxygenase-mediated prostaglandin production by the putative cancer chemopreventive flavonoids tricin, apigenin and quercetin

Synthesis and biological evaluation of novel flavonols as potential anti-prostate cancer agents

Tissue distribution in mice and metabolism in murine and human liver of apigenin and tricin, flavones with putative cancer chemopreventive properties

Physiological modeling of formulated and crystalline 3,3'-diindolylmethane pharmacokinetics following oral administration in mice

Pharmacokinetics in mice and metabolism in murine and human liver fractions of the putative cancer chemopreventive agents 3′,4′,5′,5,7-pentamethoxyflavone and tricin (4′,5,7-trihydroxy-3′,5′-dimethoxyflavone)

Preliminary safety evaluation of the putative cancer chemopreventive agent tricin, a naturally occurring flavone

Determination of anthocyanins in the urine of patients with colorectal liver metastases after administration of bilberry extract

Consumption of silibinin, a flavonolignan from milk thistle, and mammary cancer development in the C3(1) SV40 T,t antigen transgenic multiple mammary adenocarcinoma (TAg) mouse

Tissue distribution and metabolism of the putative cancer chemopreventive agent 3′,4′,5′-trimethoxyflavonol (TMFol) in mice

Determination of 3′,4′,5′,5,7-pentamethoxyflavone in the plasma and intestinal mucosa of mice by HPLC with UV detection

Marimastat: the clinical development of a matrix metalloproteinase inhibitor

Determination of the putative cancer chemopreventive flavone tricin in plasma and tissues of mice by HPLC with UV-visible detection

A simple HPLC method for the determination of apigenin in mouse tissues

Bioequivalence of two tablet formulations of capecitabine and exploration of age, gender, body surface area, and creatinine clearance as factors influencing systemic exposure in cancer patients

Somatostatin, Its Receptors and Analogs, in Lung Cancer

Phase II study of marimastat (BB-2516) in malignant melanoma: A clinical and tumor biopsy study of the National Cancer Institute of Canada Clinical Trials Group

A phase II study of Caelyx, liposomal doxorubicin : lack of activity in patients with advanced gastric cancer

Determination of the ﬂavone tricin in human plasma by high-performance liquid chromatography

Evaluation of the DNA Damaging Potential of Cannabis Cigarette Smoke by the Determination of Acetaldehyde Derived N 2 -Ethyl-2′-deoxyguanosine Adducts

Marimastat (BB2516) : Current status of development

Aktive Filter

Suchergebnisse filtern